Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert R Lavieri

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Targeted Oncology|December 9, 2017
Motivation for Launching a Cancer Metastasis Inhibition (CMI) ProgramJill M Pulley, Rebecca N Jerome, Martin L Ogletree, et al.
Molecular Cancer Therapeutics|October 9, 2020
Repurposing of a Thromboxane Receptor Inhibitor Based on a Novel Role in Metastasis Identified by Phenome-Wide Association StudyThomas A Werfel, Donna J Hicks, Bushra Rahman, et al.
Anaerobe|January 26, 2023
Walk before you run: Feasibility challenges and lessons learned from the PROCLAIM study, a multicenter randomized controlled trial of misoprostol for prevention of recurrent Clostridioides difficile during COVID-19Robert R Lavieri, Erik R Dubberke, Sarah K McGill, et al.
Frontiers in Genetics|August 16, 2021
Human and Machine Intelligence Together Drive Drug Repurposing in Rare DiseasesAnup P Challa, Nicole M Zaleski, Rebecca N Jerome, et al.
Assay and Drug Development Technologies|December 2, 2017
When Enough Is Enough: Decision Criteria for Moving a Known Drug into Clinical Testing for a New Indication in the Absence of Preclinical Efficacy DataJill M Pulley, Rebecca N Jerome, Nicole M Zaleski, et al.
Assay and Drug Development Technologies|April 6, 2017
Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human GeneticsJill M Pulley, Jana K Shirey-Rice, Robert R Lavieri, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Targeted Oncology|December 9, 2017
Motivation for Launching a Cancer Metastasis Inhibition (CMI) ProgramJill M Pulley, Rebecca N Jerome, Martin L Ogletree, et al.
Molecular Cancer Therapeutics|October 9, 2020
Repurposing of a Thromboxane Receptor Inhibitor Based on a Novel Role in Metastasis Identified by Phenome-Wide Association StudyThomas A Werfel, Donna J Hicks, Bushra Rahman, et al.
Anaerobe|January 26, 2023
Walk before you run: Feasibility challenges and lessons learned from the PROCLAIM study, a multicenter randomized controlled trial of misoprostol for prevention of recurrent Clostridioides difficile during COVID-19Robert R Lavieri, Erik R Dubberke, Sarah K McGill, et al.
Frontiers in Genetics|August 16, 2021
Human and Machine Intelligence Together Drive Drug Repurposing in Rare DiseasesAnup P Challa, Nicole M Zaleski, Rebecca N Jerome, et al.
Assay and Drug Development Technologies|December 2, 2017
When Enough Is Enough: Decision Criteria for Moving a Known Drug into Clinical Testing for a New Indication in the Absence of Preclinical Efficacy DataJill M Pulley, Rebecca N Jerome, Nicole M Zaleski, et al.
Assay and Drug Development Technologies|April 6, 2017
Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human GeneticsJill M Pulley, Jana K Shirey-Rice, Robert R Lavieri, et al.
Pageof 2